0001567619-21-010492.txt : 20210517 0001567619-21-010492.hdr.sgml : 20210517 20210517161516 ACCESSION NUMBER: 0001567619-21-010492 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210517 DATE AS OF CHANGE: 20210517 EFFECTIVENESS DATE: 20210517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CPMG Inc CENTRAL INDEX KEY: 0001372218 IRS NUMBER: 770616887 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18547 FILM NUMBER: 21930782 BUSINESS ADDRESS: STREET 1: 2000 MCKINNEY STREET 2: SUITE 2125 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 214-871-6816 MAIL ADDRESS: STREET 1: 2000 MCKINNEY STREET 2: SUITE 2125 CITY: DALLAS STATE: TX ZIP: 75201 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001372218 XXXXXXXX 03-31-2021 03-31-2021 CPMG Inc

2000 MCKINNEY SUITE 2125 DALLAS TX 75201

13F HOLDINGS REPORT 028-18547 Y This Form 13F includes only the reportable 2,896,901 Class A shares of Reata Pharmaceuticals, Inc. ("Reata") over which CPMG, Inc. ("CPMG") had investment discretion as of March 31, 2021. This Form 13F does not include the 1,692,857 Class B shares of Reata over which CPMG had investment discretion as of March 31, 2021 because such Class B shares were not included in the relevant quarter's Official List of Section 13(f) Securities, and thus should be excluded. John E. Bateman 214-871-6816 /s/ John E. Bateman Dallas TX 05-17-2021 0 4 522860 false INFORMATION TABLE 2 form13fInfoTable.xml APOLLO ENDOSURGERY INC COM 03767D108 17466 3169845 SH SOLE 3169845 0 0 INSTIL BIO INC COM 45783C101 212648 8478790 SH SOLE 8478790 0 0 INVESCO QQQ TR UNIT SER 1 46090E103 3925 12299 SH SOLE 12299 0 0 REATA PHARMACEUTICALS INC CL A 75615P103 288821 2896901 SH SOLE 2896901 0 0